Cronos Group Inc. - Common Share (CRON)

The past, present, and future of the Canadian cannabis sector.

Income investors looking for a high dividend stock for 2025 should consider Altria Group Inc. The company has a long history of reliable dividend hikes.

The past, present and future of the Canadian cannabis sector.

British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.

This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch.

CRON earnings call for the period ending December 31, 2024.

Cronos' Q4 sales rose to $30.3M but missed estimates. Gross profit surged, and adjusted EBITDA loss improved as the company eyes long-term growth.

Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook.

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Cronos CEO Mike Gorenstein discusses Trump's potential for cannabis reform, challenges the "blue state" myth, and Cronos' focus...

In the third quarter, Cronos' Spinach brand became the best-selling cannabis brand in the Canadian adult-use market and their Peace Naturals brand held a top spot in the Israeli medical market.

Cronos stock just went up -- a lot. Maybe it's time to sell?

CRON earnings call for the period ending September 30, 2024.

Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.

Cronos' Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared to a net loss of $1.6 million in the prior year's period. The company has set an operating expense savings target of $5 to $10 million for 2024,

Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.